Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > Will todays strategic mineral announcement help VM?

<< Previous

Bullboard Posts

Next >>

Comment by Billybubon Dec 10, 2022 9:20am

93 Views

Post# 35163675

RE:RE:Will todays strategic mineral announcement help VM?

They should be able to secure a $10 million loc.
just pay interest as they draw down and initially pay interest with new shares.
since governments haven't helped the company maybe the board will pay profits as shareholder dividends in future.
I can't believe that Alberta and federal governments have not put money into this company.
maybe if it could be used in batteries they might get noticed!

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals